SCHEMBL11446547

SCHEMBL11446547

Cc1ccc(N(C(=O)CCCl)C2CCCC2N(C)C)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MITF O75030 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ PAX8 Q06710 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ OPRM1 P35372 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CNR1 P21554 2/20 0.32
▸ CNR2 P34972 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.32
▸ POLB P06746 2/20 0.32
▸ MLYCD O95822 1/20 0.32
▸ TRPM8 Q7Z2W7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11341133 0.96 RAB9A (0.40) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL11446841 0.91 SIGMAR1 (0.40) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL11446847 0.88 MEN1 (0.41) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL11446684 0.88 ALDH1A1 (0.51) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL11446891 0.88 MEN1 (0.40) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL11436730 0.87 ALDH1A1 (0.38) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL11332175 0.87 SIGMAR1 (0.42) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL11465500 0.86 KMT2A (0.37) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL11456934 0.86 SMN1; SMN2 (0.34) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL11330943 0.85 MEN1 (0.40) NPC1RAB9AMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4204003-A N-(2-Aminocyclopentyl)-N-alkanoylanilides as CNS anti-depressants THE UPJOHN COMPANY (US) 1980-05-20 — — US claimed
US-4204003-A N-(2-Aminocyclopentyl)-N-alkanoylanilides as CNS anti-depressants THE UPJOHN COMPANY (US) 1980-05-20 — — US disclosed
US-4159340-A N-(2-Aminocyclopentyl)-N-acylanilides as CNS anti-depressants THE UPJOHN COMPANY (US) 1979-06-26 — — US disclosed
US-4157398-A N-(2-Aminocyclopentyl)acylanilides and treating depression THE UPJOHN COMPANY (US) 1979-06-05 — — US disclosed
US-4156733-A ANTIDEPRESSANTS THE UPJOHN COMPANY (US) 1979-05-29 — — US disclosed
US-4156015-A N-(2-Aminocyclopentyl)acylanilides and treating depression THE UPJOHN COMPANY (US) 1979-05-22 — — US disclosed
US-4148913-A ANTIDEPRESSANTS THE UPJOHN COMPANY (US) 1979-04-10 — — US disclosed
Send feedback